Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model.
Meiser
B M
BM
Department of Cardiac Surgery, Ludwig Maximilians University of Munich, Germany.
Wolf
S
S
Devens
C
C
Wenke
K
K
Thiery
J
J
Kreuzer
E
E
Hammer
C
C
Billingham
M E
ME
Reichart
B
B
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects* / Q000473:pathology; D006084:Graft Rejection; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology*; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D009842:Oligopeptides / Q000008:administration & dosage / Q000494:pharmacology*; D010456:Peptides, Cyclic; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D016559:Tacrolimus / Q000633:toxicity*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D009842:Oligopeptides; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D016559:Tacrolimus